Vistin Pharma ASA acquires 15% stake in Hungary's CF Pharma, an API CDMO, for up to MEUR 1.6.
Vistin Pharma ASA acquires 15% share in Hungary's CF Pharma, an API CDMO with a proven track record in developing and commercializing Active Pharmaceutical Ingredients (APIs). The transaction price consists of a base price and an earn-out-element, with an agreed cap of MEUR 1.6. The deal marks the beginning of potential closer partnership in the future, broadening Vistin Pharma's product portfolio and providing an important basis for future growth.
March 04, 2024
4 Articles